Name: FENNEC PHARMACEUTICALS INC (FENC) Stock
Brand: FENNEC PHARMACEUTICALS INC
Rating: 4 (3 reviews)

FENC Latest News, Press Relases and Analysis

All

Press Releases

21 hours ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss

7 days ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference

14 days ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption

15 days ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada

15 days ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

4 months ago - By: The Motley Fool

Fennec Q2 Sales Jump 33 Percent

4 months ago - By: Benzinga

Fennec Pharmaceuticals Earnings Preview

7 months ago - By: Zacks Investment Research - Mentions: JYNT EHC WGS

The Joint Misses Q1 Earnings Estimates on Rising Expenses

19 days ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada

19 days ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares

19 days ago - By: Zacks Investment Research - Mentions: VREX

Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue Estimates

19 days ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Announces Proposed Offering of Common Shares

19 days ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

20 days ago - By: Zacks Investment Research - Mentions: BOLT

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

a month ago - By: Zacks Investment Research - Mentions: NAGE

Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates

a month ago - By: Zacks Investment Research - Mentions: URGN

Adherex Technologies Inc. (FENC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

4 months ago - By: The Motley Fool

Fennec (FENC) Q2 2025 Earnings Call Transcript

4 months ago - By: Zacks Investment Research - Mentions: OCS

Adherex Technologies Inc. (FENC) Reports Q2 Loss, Beats Revenue Estimates

4 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update

4 months ago - By: Benzinga - Mentions: BTCM DE TIC DFLI ...

Earnings Scheduled For August 14, 2025

4 months ago - By: Zacks Investment Research - Mentions: CDXS

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

4 months ago - By: Zacks Investment Research - Mentions: CUE

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

4 months ago - By: Zacks Investment Research - Mentions: ROIV

Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates

4 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025

4 months ago - By: Zacks Investment Research - Mentions: CON

Concentra Group (CON) Matches Q2 Earnings Estimates

6 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Announces Results of Annual Meeting

7 months ago - By: Zacks Investment Research - Mentions: ACHC EHC WGS

Acadia Healthcare Q1 Earnings Top Estimates on Rising Admissions

7 months ago - By: Zacks Investment Research - Mentions: BHST

Adherex Technologies Inc. (FENC) Reports Q1 Loss, Tops Revenue Estimates

7 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

7 months ago - By: Zacks Investment Research - Mentions: CUE

Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates

7 months ago - By: Zacks Investment Research - Mentions: ACAD

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings and Revenue Estimates (Revised)

7 months ago - By: Zacks Investment Research - Mentions: ABCL

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates

7 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

7 months ago - By: Zacks Investment Research - Mentions: ACAD

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings and Revenue Estimates

7 months ago - By: Zacks Investment Research

Wall Street Analysts See an 113.25% Upside in Adherex Technologies (FENC): Can the Stock Really Move This High?

9 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FRX.CA

FENNEC PHARMACEUTICALS INC (FENC) Stock News

FENC Latest News, Press Relases and Analysis

Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss

Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference

Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption

Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada

Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

Fennec Q2 Sales Jump 33 Percent

Fennec Pharmaceuticals Earnings Preview

The Joint Misses Q1 Earnings Estimates on Rising Expenses

Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada

Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares

Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue Estimates

Fennec Pharmaceuticals Announces Proposed Offering of Common Shares

Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates

Adherex Technologies Inc. (FENC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Fennec (FENC) Q2 2025 Earnings Call Transcript

Adherex Technologies Inc. (FENC) Reports Q2 Loss, Beats Revenue Estimates

Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update

Earnings Scheduled For August 14, 2025

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates

Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025

Concentra Group (CON) Matches Q2 Earnings Estimates

Fennec Announces Results of Annual Meeting

Acadia Healthcare Q1 Earnings Top Estimates on Rising Admissions

Adherex Technologies Inc. (FENC) Reports Q1 Loss, Tops Revenue Estimates

Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings and Revenue Estimates (Revised)

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates

Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings and Revenue Estimates

Wall Street Analysts See an 113.25% Upside in Adherex Technologies (FENC): Can the Stock Really Move This High?

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update